Literature DB >> 18404677

Histone deacetylase 5 represses the transcription of cyclin D3.

Sangita Roy1, Audrey C Shor, Tapan K Bagui, Edward Seto, W Jackson Pledger.   

Abstract

Histone deacetylases (HDACs) modulate the transcription of a subset of genes by various means. HDAC5 is a class II HDAC whose subcellular location is signal-dependent. At present, its known gene targets are few in number. Here we identify a new HDAC5 target: the gene encoding the cell cycle-regulatory protein cyclin D3. When overexpressed in Balb/c-3T3 cells or mouse embryo fibroblasts, HDAC5 substantially reduced the activity of the cyclin D3 promoter and the abundance of endogenous cyclin D3 protein. Conversely, conditions that blocked HDAC5 function increased cyclin D3 expression: treatment of cells with the class I/II HDAC inhibitor trichostatin A (TSA), depletion of HDAC5 from cells by RNA interference, and cytoplasmic sequestration of HDAC5 by co-expression of catalytically active calcium/calmodulin-dependent protein kinase. HDAC5 interacted with the cyclin D3 promoter in vivo, and the HDAC5-responsive element was within 118 base pairs upstream of the transcription start site. Mutation of the Sp1 site and the cyclic AMP response element within this region did not affect the responsiveness of the cyclin D3 promoter to HDAC5 or TSA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18404677     DOI: 10.1002/jcb.21771

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Microarray study of mechanism of trichostatin a inducing apoptosis of Molt-4 cells.

Authors:  Zhenya Hong; Zhiqiang Han; Min Xiao; Yang Yang; Xi Xia; Jianfeng Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

2.  Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation.

Authors:  Todd M Greco; Fang Yu; Amanda J Guise; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2010-11-16       Impact factor: 5.911

3.  HDAC5 promotes osteosarcoma progression by upregulation of Twist 1 expression.

Authors:  Jie Chen; Jun Xia; Yong-lin Yu; Si-qun Wang; Yi-bing Wei; Fei-yan Chen; Gang-yong Huang; Jing-sheng Shi
Journal:  Tumour Biol       Date:  2013-10-05

4.  Translational repression of cyclin D3 by a stable G-quadruplex in its 5' UTR: implications for cell cycle regulation.

Authors:  Heng-You Weng; Hui-Lin Huang; Pan-Pan Zhao; Hui Zhou; Liang-Hu Qu
Journal:  RNA Biol       Date:  2012-08-01       Impact factor: 4.652

Review 5.  Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.

Authors:  Andrea Clocchiatti; Cristina Florean; Claudio Brancolini
Journal:  J Cell Mol Med       Date:  2011-09       Impact factor: 5.310

Review 6.  Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer.

Authors:  Zohaib Rana; Sarah Diermeier; Muhammad Hanif; Rhonda J Rosengren
Journal:  Biomedicines       Date:  2020-01-30

7.  Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.

Authors:  Jilong Yang; Matti Annala; Ping Ji; Guowen Wang; Hong Zheng; David Codgell; Xiaoling Du; Zhiwei Fang; Baocun Sun; Matti Nykter; Kexin Chen; Wei Zhang
Journal:  J Hematol Oncol       Date:  2014-10-10       Impact factor: 17.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.